References – Activeforever CIDEX Plus Solution User Manual
Page 6
33 Technology Drive • Irvine CA 92618 • (888) 783-7723
AD-090186-01-US_A ©ASP 2009
References
1. Centers for Disease Control and Prevention. Public health focus: Surveillance, prevention and control of nosocomial infections. Morbidity and Mortality
Weekly Report. 1992;41(42):783–787.
2. Joint Commission 2009 National Patient Safety Goals—Hospital 2008.
3. APIC Vision 2012. Washington, D.C.: Association for Professionals in Infection Control and Epidemiology.
4. Mitka M. Public, private insurers refusing to pay hospitals for costs of avoidable errors. JAMA. 2008;299:2495–2496.
5. Mehta A, Prakash U, Garland R, et al. Prevention of flexible bronchoscopy-associated infection. Chest. 2005;128:1742–1755.
6. Nelson D, Jarvis W, Rutala W, et al. Multi-society guideline for reprocessing flexible gastrointestinal endoscopes. Infect Control Hosp Epidemiol.
2003;24:532–537.
7. Rutala W, Weber D. Disinfection of Endoscopes: Review of new chemical sterilants used for high-level disinfection. Infect Control Hosp Epidemiol.
1999;20:69–76.
8. Spach D, Silverstein F, Stamm W. Transmission of infection by gastrointestinal endoscopy and bronchoscopy. Ann Intern Med. 1993;118:117–128.
9. Miller M. ICRE-1108: Instrument processing overview: cleaning, disinfection, sterilization. http://www.iceinstitute.com/. Accessed Nov. 11, 2008.
10. Association for Professionals in Infection Control and Epidemiology (APIC). Disinfection and sterilization principles; 2002.
11. Committee on Antimicrobial Efficacy Testing. Methods Committee Report. J AOAC Int. 2008;91:68B–72B.
12. Abraham J, Abdelshehid C, Lee H, et al. Effects of Steris 1™ sterilization and Cidex
®
ortho-phthalaldehyde high-level disinfection on durability of
new-generation flexible ureteroscopes. J Endourol. 2007;21:985–992.
13. Roberts C, Chan-Myers H. Efficacy of dilute ortho-phthalaldehyde solutions with glutaraldehyde-resistant mycobacteria. American Society for
Microbiology; 1998; Atlanta.
14. Roberts C, Chan-Myers H, Ascenzi J. Activity of dilute ortho-phthalaldehyde solutions against drug-resistant bacteria. American Society for
Microbiology; 2001; Olando.
15. Roberts C, Chan-Myers H, Favero M. Virucidal activity of ortho-phthalaldehyde solutions against hepatitis B and C viruses. Am J Infect Control.
2008;36:223–226.
16. Chan-Myers H, Roberts C. The role of temperature and concentration on the sporicidal activity of ortho-phthalaldehyde. Society for Healthcare
Epidemiologists of America; 2001; Baltimore.
17. Chan-Myers H, Roberts C. Effect of temperature and organic soil concentration on biocidal activity of ortho-phthalaldehyde solution. Association for
Professionals in Infection Control and Epidemiology (APIC); 2000.
18. van Klingeren B, Pullen W. Glutaraldehyde resistant mycobacteria from endoscope washers. Hosp Infect. 1993;25:147–149.
19. Fraud S, Maillard J, Russell A. Comparison of the mycobactericidal activity of ortho-phthalaldehyde, glutaraldehyde and other dialdehydes by a
quantitative suspension test. J Hosp Infect. 2001;48:214–221.
20. Gregory A, Schaalje G, Smart J, Robison R. The mycobactericidal efficacy of ortho-phthalaldehyde and the comparative resistance of Mycobacterium
bovis, Mycobacterium terrae, and Mycobacterium chelonae. Infect Control Hosp Epidemiol. 1999;20:324–330.
21. Fraud S, Hann A, Maillard J, Russell A. Effects of ortho-phthalaldehyde, glutaraldehyde and chlorhexidine diacetate on Mycobacterium chelonae and
Mycobacterium abscessus strains with modified permeability. JAC. 2003;51:575–584.
22. Agency for Healthcare Research and Quality. Potentially deadly infection doubles among hospital patients over last 5 years. Statistical Brief #50; 2008.
23. Chan-Myers H, Roberts C. Evaluation of the biocidal efficacy of ortho-phthalaldehyde solution with vegetative and spore forms of Clostridium difficile.
Association for Professionals in Infection Control and Epidemiology (APIC); June 15–19, 2008; Denver.
24. Sattar S, Tetro J, Springthorpe V, Guilivi A. Preventing the spread of hepatitis B and C viruses: where are germicides relevant? Am J Infect Control.
2001;29:187–197.
25. Alfa M, Olson N, Degagne P, Jackson M. A survey of reprocessing methods, residual viable bioburden, and soil levels in patient-ready endoscopic
retrograde choliangiopancreatography duodenoscopes used in Canadian centers. Infect Control Hosp Epidemiol. 2002;23:198–206.
This white paper was funded by Advanced Sterilization Products.